Recipe SPRL
3.3 FTEThe score of Recipe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -42 % Total assets -2 % Headcount (avg FTE) +57 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Recipe's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −82,392 € | ||||
| Equity | 219,747 € | ||||
| Cash | 78,727 € | ||||
| EBITDA | −35,589 € | ||||
| Total assets | 720,928 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 26 May 2025
- Year ended 31 Dec 2023filed on 23 May 2024
- Year ended 31 Dec 2022filed on 18 Sep 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Recipe's financial analysis
- Solvency30.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Recipe
Recipe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0878.084.679
- VAT number
- BE0878084679
- Peppol
- Registered · 0208:0878084679 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 21 Dec 2005
- Registered office
- 1070 Anderlecht
- Size
- Micro · 3.3 FTE
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Recipe (SPRL) has been based in Anderlecht since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 82,392 € and equity of 219,747 €; its revenue is not published. With 3.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 30.5%, below the median of its sector (37.8%).
Companies similar to Recipe
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de BALMORAL Retail sale of pharmaceutical products Chaudfontaine · balance sheet 720,927 €
- Het Apotheekhuis Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 720,768 €
- MRZK Pharma Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet 721,142 €
- VAN DEN Abeele - Waerniers Retail sale of pharmaceutical products Maldegem · balance sheet 721,160 €
- Apotheek D'haen Retail sale of pharmaceutical products Zottegem · balance sheet 720,561 €
- Farmapunt Achel Retail sale of pharmaceutical products Hamont-Achel · balance sheet 721,434 €
- Bellipharma Retail sale of pharmaceutical products Schaerbeek · balance sheet 718,811 €
- Hemifar Retail sale of pharmaceutical products Hemiksem · balance sheet 724,505 €
Frequently asked questions about Recipe
What is the revenue of Recipe?
Recipe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Recipe?
In Belgium, the VAT number is the company number prefixed with BE: BE0878084679 for Recipe, if the company is VAT-registered. Its company number (CBE) is 0878.084.679.
Where is the registered office of Recipe?
According to the CBE register, the registered office of Recipe is in 1070 Anderlecht.
What is the equity of Recipe?
At the close of the 2025 financial year, the equity of Recipe amounts to 219,747 €, a solvency of 30.5% of total assets.
How many people work at Recipe?
3.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Recipe?
The register lists 2 active mandates at Recipe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Recipe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →